Key result
PFA-100 closure times and VWF levels were strongly related, but PFA-100 did not significantly improve the diagnostic capability of VWF antigen measurement for type 1 von Willebrand disease.
Why the study?
Does PFA-100 closure time improve the diagnosis of type 1 von Willebrand disease compared to VWF antigen measurement?
Observational (n=362)
Yes
Does PFA-100 closure time improve the diagnosis of type 1 von Willebrand disease compared to VWF antigen measurement?
Answers are grounded in this paper and cite their sources.
PFA-100 closure time does not significantly improve the diagnostic capability of VWF antigen measurement for type 1 von Willebrand disease, though a normal result may help exclude it.
The relationships between the Platelet Function Analyzer (PFA)-100 and von Willebrand factor (VWF) levels and bleeding score (BS) were evaluated within a multicentre project on Molecular and Clinical Markers for the Diagnosis and Management of type 1 von Willebrand disease (MCMDM-1VWD). PFA-100 closure time, either with epinephrine (EPI) or adenosine diphosphate (ADP)-cartridges, was measured in 107 index cases, 105 affected and 71 unaffected family members, and 79 healthy controls. By regression analysis VWF levels were strongly related to both closure times, with a non-linear progression. In a multiple stepwise regression model, age- and sex-adjusted PFA-100 ADP and VWF ristocetin cofactor activity (VWF:RCo) were independently associated with BS. Most of the variation of BS was predicted by PFA-100 ADP and VWF:RCo alone. In the subgroup of patients with subtle abnormalities of the multimeric pattern, VWF was invariably reduced and closure time prolonged in almost all of them. Neither PFA-100 ADP nor EPI closure times appeared to significantly improve the diagnostic capability of VWF antigen (VWF:Ag) measurement. Thus, in an unselected population a normal PFA-100 would be useful to exclude VWD, but whether it could replace the more specific VWF assay in patients with significant mucocutaneous bleeding symptoms remains to be investigated prospectively.
No takes yet. Share an insight, caveat, or question.
Castaman et al. (2010) conducted an observational in Type 1 von Willebrand disease (n=362). PFA-100 closure time and VWF levels vs. Healthy controls and unaffected family members was evaluated on Relationship between PFA-100, VWF levels, and bleeding score. PFA-100 closure times and VWF levels were strongly related, but PFA-100 did not significantly improve the diagnostic capability of VWF antigen measurement for type 1 von Willebrand disease.
Synapse has enriched 10 related papers. Consider them for comparative context: